L-Ergothioneine for Memory & Brain Health: Clinical Studies

You may have already noticed the changes — reading a paragraph and needing to go back over it again, blanking on a familiar name in the middle of a conversation, checking three times before leaving the house and still not being sure you locked the door.

Most people explain these moments away as stress. But if this has been going on for a while, you might start wondering: is there something that could give my brain a little more support?

GeneIII has partnered with a leading academic medical center to conduct a human clinical trial exploring L-Ergothioneine's potential for memory and cognitive function (ChiCTR2500112606).

Why Your Brain Needs Continuous Antioxidant Support

The brain is the most energy-demanding organ in your body.

It accounts for just 2% of body weight but consumes 20% of your total oxygen supply. That high oxygen demand generates significant free radical output, and the brain's abundant lipid content is particularly susceptible to oxidative impact.

At the same time, neurons renew far more slowly than liver cells or skin cells. This means the brain depends more on sustained protection than on after-the-fact repair.

This is why a growing body of research is exploring whether antioxidant support can help maintain cognitive function over time.

L-Ergothioneine Can Cross the Blood-Brain Barrier

The blood-brain barrier acts as a security checkpoint for your brain, blocking the vast majority of external substances from entering. This barrier protects the brain — but it also means most oral nutrients never reach brain tissue.

L-Ergothioneine is one of the few natural antioxidant compounds that can cross the blood-brain barrier.

Once inside, the OCTN1 transporter protein actively delivers it into neurons. Research shows OCTN1 is highly expressed in the brain, meaning the body not only allows L-Ergothioneine in, but actively routes it to where protection is needed.

This ability to get in and get to the right place is the core reason L-Ergothioneine has attracted research attention in brain health.

GeneIII's Brain Health Clinical Trial

GeneIII has partnered with a university-affiliated academic medical center to register an L-Ergothioneine brain health clinical trial.

Trial Registration Number: ChiCTR2500112606

The trial is currently underway, with results pending publication. You can verify the trial details yourself at chictr.org.cn by entering the registration number.

This represents an important step in GeneIII's research expansion from liver health into brain health. Together with trials in liver function (ChiCTR2400093739), menstrual pain (ChiCTR2500112557), ovarian health (ChiCTR2500104484), postpartum recovery (ChiCTR2500114171), kidney health (ChiCTR2500108897), and sperm health (ChiCTR2500111625), GeneIII now has 8 registered L-Ergothioneine human clinical trials on the ChiCTR platform.

You Can Verify Every Study Yourself

A common pattern in the supplement industry: brands cite academic literature to support their marketing, but those studies were not conducted by them and did not use their products.

GeneIII operates differently. Its clinical trials are registered with the Chinese Clinical Trial Registry, use GeneIII's own L-Ergothioneine product, and are independently conducted by leading hospitals. Completed research is published on international preprint platforms (bioRxiv, medRxiv), available in both Chinese and English.

You do not need to rely on brand claims. Enter a registration number at chictr.org.cn to see trial details. Go to bioRxiv or medRxiv to read the full study.

Brain-Relevant Findings from Other Completed GeneIII Trials

While the brain health trial results are still pending, GeneIII's data from other areas offers two relevant signals:

Sleep quality improved significantly. In the liver health trial (ChiCTR2400093739), participants taking 60mg daily for 30 days saw a 51% reduction in sleep disturbance scores. Sleep is when the brain clears metabolic waste — improved sleep quality may have an indirect positive effect on cognitive function.

Systemic inflammatory markers decreased. In GeneIII's exercise study (bioRxiv preprint, DOI: 10.64898/2026.02.19.706732), L-Ergothioneine reduced pro-inflammatory cytokines IL-1β, IL-6, and TNF-α across the board. The relationship between chronic inflammation and cognitive function is an active area of neuroscience research.

These results come from open-label designs, and larger randomized controlled trials are warranted to confirm the findings.

About GeneIII L-Ergothioneine Capsules

GeneIII L-Ergothioneine capsules reach 99.99% purity, verified by third-party HPLC analysis. Production follows cGMP pharmaceutical-grade standards, with GeneIII controlling the entire chain from strain engineering to commercial manufacturing — backed by 33 patents.

GeneIII holds FDA GRAS certification (GRN 001270). In the United States, 539 licensed clinicians have awarded it the Clinicians' Choice designation on Front Row MD.

Each capsule contains 30mg of L-Ergothioneine in an HPMC plant-based shell, free from dairy, shellfish, peanuts, artificial sweeteners, and artificial preservatives. Recommended intake is 1–2 capsules daily. The optimal dosage specifically for cognitive health will be further informed by the ongoing clinical trial.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.